Capozzi, Andrea http://orcid.org/0000-0002-2306-9049
Kilund, Jan
Karlsson, Magnus
Patel, Saket
Pinon, Arthur Cesar
Vibert, François
Ouari, Olivier
Lerche, Mathilde H.
Ardenkjær-Larsen, Jan Henrik http://orcid.org/0000-0001-6167-6926
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSK-2_190547, PZ00P2_193276)
EC | Horizon 2020 Framework Programme (713683, 713683)
Article History
Received: 3 March 2021
Accepted: 8 June 2021
First Online: 23 June 2021
Competing interests
: Professor Ardenkjær-Larsen is CEO of the startup company Polarize. Polarize sells dDNP equipment for pre-clinical studies. All other authors declare no competing interests.